Content about Wade Miquelon

January 8, 2014

Walgreens is not only completely transforming its drug store business from a prescription medicine dispensary to healthcare provider, they're continuing to deliver shareholder value.

CHICAGO — Walgreens is not only completely transforming its drug store business from a prescription medicine dispensary to healthcare provider, they're continuing to deliver shareholder value. Since the chain implemented its "Plan to Win" strategy five years ago, kicking off Walgreens journey to reinvent and innovate the storied drug store chain for a new era of growth and value creation, Walgreens has delivered 145% in shareholder returns vs. the 118% return realized by the S&P 500 in the same period. 

December 20, 2013

Walgreens posted a first-quarter sales increase of 5.9% to a record $18.3 billion. Front-end comparable store sales for the quarter increased 2.4% in the first quarter, customer traffic in comparable stores increased 0.2% and basket size increased 2.2%, while total sales in comparable stores increased 5.4%. Prescription sales, which accounted for 64.7% of sales in the quarter ended Nov. 30, increased 7.3%, while prescription sales in comparable stores increased 7.2%.

Front-end comps are up. Prescription comps are up. Business is good. And that's not the story. Rather, that's the kind of results you can expect from the story. The story is Walgreens is priming a three-pistoned growth engine that will quite likely drive what pharmacy will look like in the future — an efficient global supply chain beast that feeds a front-end that commands traffic in its own right, and a back-end that demands healthcare payers pay attention to how Walgreens can help improve adherence and patient-care metrics. So, how can suppliers better align with Walgreens?

Walgreens posted a first-quarter sales increase of 5.9% to a record $18.3 billion. Front-end comparable store sales for the quarter increased 2.4% in the first quarter, customer traffic in comparable stores increased 0.2% and basket size increased 2.2%, while total sales in comparable stores increased 5.4%. Prescription sales, which accounted for 64.7% of sales in the quarter ended Nov. 30, increased 7.3%, while prescription sales in comparable stores increased 7.2%.

November 12, 2013

The Chicagoland Area Affiliate of Susan G. Komen (Komen Chicago) on Tuesday announced that Walgreens CFO and president international Wade Miquelon will serve as race chair for its annual Susan G. Komen Chicagoland Race for the Cure. The event will take place on Mother's Day, May 11, 2014, in Chicago's Grant Park.

CHICAGO — The Chicagoland Area Affiliate of Susan G. Komen (Komen Chicago) on Tuesday announced that Walgreens CFO and president international Wade Miquelon will serve as race chair for its annual Susan G. Komen Chicagoland Race for the Cure. The event will take place on Mother's Day, May 11, 2014, in Chicago's Grant Park.

October 31, 2012

Walgreens on Tuesday announced that it has formally set up a new company, jointly owned with Alliance Boots, as part of their strategic partnership’s synergy program.

DEERFIELD, Ill. — Walgreens on Tuesday announced that it has formally set up a new company, jointly owned with Alliance Boots, as part of their strategic partnership’s synergy program.

The new company, called Walgreens Boots Alliance Development, will be based in Bern, Switzerland.

No other details were released. 

September 28, 2012

Fiscal 2012 is now in Walgreens' rearview mirror as the company looks ahead toward 2013 with its foot on the accelerator

 DEERFIELD, Ill. — Fiscal 2012 now is in Walgreens' rearview mirror as the company looks ahead toward 2013 with its foot on the accelerator. A re-entry into the Express Scripts pharmacy provider network, a new loyalty card and synergies borne out of the Alliance Boots partnership will all help fuel Walgreens' health-and-wellness engine. 

Walgreens stock was up slightly within the half-hour of the call to approximately $36.70 per share. WAG had closed Thursday at $36.52 and opened Friday morning at $36.27. 

September 25, 2012

A carrot, a stick and a face-to-face encounter. Those are the tools that will chisel away at healthcare costs, noted Wade Miquelon, Walgreens EVP and CFO. And Walgreens is uniquely positioned to help realize those savings. 


A carrot, a stick and a face-to-face encounter. Those are the tools that will chisel away at healthcare costs, noted Wade Miquelon, Walgreens EVP and CFO. And Walgreens is uniquely positioned to help realize those savings. 


To lower costs, you could raise co-pays or premiums to discourage unhealthy behaviors like smoking, poor diet or lack of exercise. That’s the stick. On the other hand, you could waive co-pays or a reduce premiums to help encourage healthy behaviors like regular checkups or disease-state management programs. That’s the carrot. 


September 25, 2012

In June, Walgreens announced a two-step investment in a strategic partnership with Alliance Boots, to acquire a 45% equity stake in the privately held company for $6.7 billion in cash and stock in the first step with the option to acquire the other 55% approximately three years down the road at what is today being projected to be another $9.5 billion price tag in cash and stock. 


In June, Walgreens announced a two-step investment in a strategic partnership with Alliance Boots, to acquire a 45% equity stake in the privately held company for $6.7 billion in cash and stock in the first step with the option to acquire the other 55% approximately three years down the road at what is today being projected to be another $9.5 billion price tag in cash and stock. 


September 18, 2012

Walgreens on Tuesday announced several new senior management roles, including an expanded role for CFO Wade Miquelon and the appointment of current SVP and chief strategy officer Robert Zimmerman as the lead executive responsible for the Walgreens-Alliance Boots' "synergy team."

DEERFIELD, Ill. — Walgreens on Tuesday announced several new senior management roles, including an expanded role for CFO Wade Miquelon and the appointment of current SVP and chief strategy officer Robert Zimmerman as the lead executive responsible for the Walgreens-Alliance Boots' "synergy team." Succeeding Zimmerman as chief strategy officer will be Brad Fluegel.

June 19, 2012

The days of Walgreens quarterly conference calls focusing primarily on lost prescriptions from the Express Scripts pharmacy network soon may be over with the retail pharmacy's announcement early Tuesday morning that Walgreens and the U.K. pharmacy operation Alliance Boots would merge.

DEERFIELD, Ill. — The days of Walgreens quarterly conference calls focusing primarily on lost prescriptions from the Express Scripts pharmacy network soon may be over with the retail pharmacy's announcement early Tuesday morning that Walgreens and the U.K. pharmacy operation Alliance Boots would merge.

April 4, 2012

Walgreens posted March sales of $6 billion, a decrease of 4.3% compared with the same month in fiscal year 2011.

DEERFIELD, Ill. — Walgreens posted March sales of $6 billion, a decrease of 4.3% compared with the same month in fiscal year 2011.

January 25, 2012

Acadia Healthcare on Wednesday announced that it has named Walgreens veteran Wade Miquelon to its board of directors.

FRANKLIN, Tenn. — Acadia Healthcare on Wednesday announced that it has named Walgreens veteran Wade Miquelon to its board of directors.

"Wade Miquelon brings tremendous expertise in a range of disciplines to Acadia, as well as valuable perspectives from his work with both large established companies and young growth companies," stated Joey Jacobs, Acadia chairman and CEO. "We welcome Wade to the board, confident of his ability to contribute to the company's long-term growth in earnings and shareholder value."

November 16, 2011

Walgreens took to the road the week before Thanksgiving to talk turkey with analysts on why Walgreens is a good bet going into 2012, even if the pharmacy won't be participating in the Express Scripts pharmacy network this coming year.

NEW YORK — Walgreens took to the road the week before Thanksgiving to talk turkey with analysts on why Walgreens is a good bet going into 2012, even if the pharmacy won't be participating in the Express Scripts pharmacy network this coming year.

June 23, 2011

Walgreens CFO Wade Miquelon said that the chain's decision to break its ties with pharmacy benefit manager Express Scripts was the best decision, according to a Reuters report.

NANTUCKET, Mass. — Walgreens CFO Wade Miquelon said that the chain's decision to break its ties with pharmacy benefit manager Express Scripts was the best decision, according to a Reuters report.

Caling it a "principled stand," Miquelon, who spoke at the Jefferies 2011 Global Consumer Conference in Nantucket, Mass., on Thursday, said that "under any scenario of what Express Scripts is proposing ... it's much better for us to go it alone," Reuters reported.